Cargando…
Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
BACKGROUND: Substantial evidence indicates that β-catenin is a pivotal regulator that contributes to the initiation and development of various types of diseases. Recently, β-catenin can be detected in human serum and also reported to be correlated with several disease progression in a little researc...
Autores principales: | Duan, Liang, Yang, Qianfan, Yang, Jun, Hu, Qin, Wang, Bo, Li, Pu, Chen, Weixian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162905/ https://www.ncbi.nlm.nih.gov/pubmed/30268125 http://dx.doi.org/10.1186/s12967-018-1645-x |
Ejemplares similares
-
Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders
por: Chen, Shu, et al.
Publicado: (2020) -
SIP1 serves a role in HBx-induced liver cancer growth and metastasis
por: Ye, Yuanyuan, et al.
Publicado: (2019) -
Serum Expression of β-Catenin Is a Potential Detection Marker in Patients with Colorectal Cancer
por: Li, Shue, et al.
Publicado: (2019) -
Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure
por: Zhang, Lili, et al.
Publicado: (2022) -
Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases
por: Wu, JianPing, et al.
Publicado: (2020)